These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31818266)

  • 1. Protocol for a prospective, cluster randomized trial to evaluate routine and deferred dialysis initiation (RADDI) in Chinese population.
    Zhao X; Wang P; Wang L; Chen X; Huang W; Mao Y; Hu R; Cheng X; Wang C; Wang L; Zhang P; Li D; Wang Y; Ye W; Chen Y; Jia Q; Yan X; Zuo L
    BMC Nephrol; 2019 Dec; 20(1):455. PubMed ID: 31818266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.
    Crews DC; Scialla JJ; Boulware LE; Navaneethan SD; Nally JV; Liu X; Arrigain S; Schold JD; Ephraim PL; Jolly SE; Sozio SM; Michels WM; Miskulin DC; Tangri N; Shafi T; Wu AW; Bandeen-Roche K;
    Am J Kidney Dis; 2014 May; 63(5):806-15. PubMed ID: 24508475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.
    Fu EL; Evans M; Carrero JJ; Putter H; Clase CM; Caskey FJ; Szymczak M; Torino C; Chesnaye NC; Jager KJ; Wanner C; Dekker FW; van Diepen M
    BMJ; 2021 Nov; 375():e066306. PubMed ID: 34844936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity promotion for patients transitioning to dialysis using the "Exercise is Medicine" framework: a multi-center randomized pragmatic trial (EIM-CKD trial) protocol.
    Jagannathan R; Ziolkowski SL; Weber MB; Cobb J; Pham N; Long J; Anand S; Lobelo F
    BMC Nephrol; 2018 Sep; 19(1):230. PubMed ID: 30208854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trial.
    Chen J; Liu Y; Chen X; Sun X; Li W; Yang W; Li P; Sun X; Wang D; Jiang H; Shi W; Liu W; Fu P; Ding X; Chang M; Liu S; Yang X; Cao N; Chen M; Ni Z; Chen J; Sun S; Liang X; Wang H; He Y; Gao B; Wang J; Hao L; Liu J; Li S; He Q; Liu H; Yi N; Shao F; Jiao J; Ma Y; Yao L; Sun Y; Li D; Szczech L; Fang M; Odeh Z; Lin H
    BMJ Open; 2019 Sep; 9(9):e023162. PubMed ID: 31501092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge Translation Interventions to Improve the Timing of Dialysis Initiation: Protocol for a Cluster Randomized Trial.
    Chau EM; Manns BJ; Garg AX; Sood MM; Kim SJ; Naimark D; Nesrallah GE; Soroka SD; Beaulieu M; Dixon S; Alam A; Tangri N;
    Can J Kidney Health Dis; 2016; 3():2054358116665257. PubMed ID: 28270916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimisation of dialysis risk in hospital patients with chronic kidney disease (MinDial): study protocol for a multicentre, stepped-wedge, cluster-randomised controlled trial.
    Stelzer D; Binder H; Glattacker M; Graf E; Hahn M; Hollenbeck M; Kaier K; Kowall B; Kuklik N; Metzner G; Mueller N; Seiler L; Stolpe S; Blume C
    Trials; 2024 Jun; 25(1):368. PubMed ID: 38849916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents.
    Okuda Y; Soohoo M; Tang Y; Obi Y; Laster M; Rhee CM; Streja E; Kalantar-Zadeh K
    Am J Kidney Dis; 2019 Jun; 73(6):797-805. PubMed ID: 30833086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
    Kimura K; Hosoya T; Uchida S; Inaba M; Makino H; Maruyama S; Ito S; Yamamoto T; Tomino Y; Ohno I; Shibagaki Y; Iimuro S; Imai N; Kuwabara M; Hayakawa H; Ohtsu H; Ohashi Y;
    Am J Kidney Dis; 2018 Dec; 72(6):798-810. PubMed ID: 30177485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of symptoms of depression with progression of CKD.
    Tsai YC; Chiu YW; Hung CC; Hwang SJ; Tsai JC; Wang SL; Lin MY; Chen HC
    Am J Kidney Dis; 2012 Jul; 60(1):54-61. PubMed ID: 22495469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
    Mathew RO; Maron DJ; Anthopolos R; Fleg JL; O'Brien SM; Rockhold FW; Briguori C; Roik MF; Mazurek T; Demkow M; Malecki R; Ye Z; Kaul U; Miglinas M; Stone GW; Wald R; Charytan DM; Sidhu MS; Hochman JS; Bangalore S
    Circ Cardiovasc Qual Outcomes; 2022 Oct; 15(10):e008995. PubMed ID: 36193750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis timing may be deferred toward very late initiation: An observational study.
    Chang YL; Wang JS; Yeh HC; Ting IW; Huang HC; Chiang HY; Hsiao CT; Chu PL; Kuo CC
    PLoS One; 2020; 15(5):e0233124. PubMed ID: 32401817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
    Imai E; Maruyama S; Nangaku M; Hirakata H; Hayashi T; Narita I; Kono H; Nakatani E; Morita S; Tsubakihara Y; Akizawa T
    Clin Exp Nephrol; 2016 Feb; 20(1):71-6. PubMed ID: 26081567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.